Literature DB >> 1685071

Variation of slow-wave frequency and locking during the migrating myoelectric complex in dogs.

P Caenepeel1, W Janssens, A Accarino, J Janssens, G Vantrappen, H Eyssen.   

Abstract

Slow waves determine rhythm and polarity of spike bursts. We measured the variation of slow-wave frequency (swf) and locking (swl) in the canine jejunum during the various phases of the migrating myoelectric complex (MMC) and during induced phase III (erythromycin 125 micrograms/kg iv bolus or somatostatin 2.5 micrograms.kg-1.h-1 iv infusion), blocked phase III (atropine 20 micrograms/kg iv bolus), and so-called stationary phase III activity (cisapride 150 micrograms/kg iv bolus). The EMG of 4 dogs, implanted with 10 bipolar electrodes, was recorded on a polygraph. Our results indicate that swf and swl change during the MMC from a stepwise swf gradient with slow waves locked in plateaus during phase I to a continuous swf gradient without or with significantly reduced phase locking during phase III. The length of the first swf plateau decreases significantly from 42 +/- 12 cm post Treitz during phase I to 11 +/- 4 cm during spontaneous phase III. Atropine block of phase III activity prevents phase unlocking and development of a continuous swf gradient. Our hypothesis is that phase unlocking may be one of the induction mechanisms of spike-burst activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685071     DOI: 10.1152/ajpgi.1991.261.6.G1079

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  2 in total

1.  Migrating motor complexes do not require electrical slow waves in the mouse small intestine.

Authors:  Nick J Spencer; Kenton M Sanders; Terence K Smith
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

2.  Relation between slow-wave frequency and spiking activity during the migrating myoelectric complex in dogs.

Authors:  W Janssens; H Vandenbogaerde; P Caenepeel; J Janssens; G Vantrappen
Journal:  Pflugers Arch       Date:  1992-08       Impact factor: 3.657

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.